Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study (STREAM-AD)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05131477 |
Recruitment Status :
Completed
First Posted : November 23, 2021
Last Update Posted : April 30, 2024
|
Sponsor:
Kymab Limited
Collaborator:
Sanofi
Information provided by (Responsible Party):
Kymab Limited
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | April 26, 2023 |
Actual Study Completion Date : | February 21, 2024 |
Certification/Extension First Submitted : | April 24, 2024 |